Deerfield Management Co. LP (Private Equity)

Deerfield Management Co. LP (Private Equity)

Deerfield Management Co. LP (Private Equity)

Overview
Date Founded

1994

Headquarters

780 Third Avenue,37th floor,New York, NY 10017-2024

Type of Company

Private

Industries

Private Equity & Venture Capital
Investment Services & Portfolio Management

Company Description

Deerfield Management Co. LP (Private Equity) invests in a broad range of industries. It provides financing for buyout transactions to private and public companies located in the U.S.

Executives & Employees

Managing Partner

Partner

Partner

Principal

Paths to Deerfield Management Co. LP (Private Equity)
Potential Connections via
Relationship Science
You
Deerfield Management Co. LP (Private Equity)
Recent Transactions
Details Hidden

Zafgen, Inc. purchases Chondrial Therapeutics, Inc. from Deerfield Management Co. LP (Private Equity)

Details Hidden

NewLink Genetics Corp. purchases Lumos Pharma, Inc. from New Enterprise Associates, Roche Ventures, Clarus Ventures LLC, SHVMS, LLC, Deerfield Management Co. LP (Private Equity)

Details Hidden

Hill-Rom Holdings, Inc. purchases Breathe Technologies, Inc. from Delphi Ventures, Inc., Life Science Angels, Vedanta Capital LLC, Synergy Ventures, Morgan Creek Capital Management (Private Equity), BioMed Ventures, Deerfield Management Co. LP (Private Equity)

Transaction Advisors
Escrow Agent

Advised onAtriCure Inc. purchases SentreHEART, Inc. from Vivo Capital LLC, Prospect Venture Partners, U.S. Venture Partners, Pinnacle Ventures LLC, Decheng Capital LLC, Deerfield Management Co. LP (Private Equity)

Investments
Details Hidden

ARS Pharmaceuticals is dedicated to empowering at-risk patients and caregivers to better protect themselves from severe allergic reactions that could lead to anaphylaxis. The Company is developing ARS-1, an intranasal epinephrine spray with a unique absorption technology that could be easy-to-use, convenient and more reliable for patients and loved ones at-risk of severe allergic reactions to food, medications and insect bites that could lead to life-threatening anaphylaxis.

Details Hidden

SHINE Medical Technologies, Inc. manufactures radioisotopes for nuclear medicine. Its products include Molybdenum-99, Iodine-131, Iodine-125, and Xenon-133. The company was founded by Gregory R. Piefer and is headquartered in Monona, WI.

Details Hidden

Dracen Pharmaceuticals, Inc. develops immuno-metabolism drugs. The company was founded by Barbara Slusher, Jonathan D. Powell, Pavel Majer, and Rana Rais and is headquartered in Baltimore, MD.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Deerfield Management Co. LP (Private Equity). The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Deerfield Management Co. LP (Private Equity)'s profile does not indicate a business or promotional relationship of any kind between RelSci and Deerfield Management Co. LP (Private Equity).